Originally published byEU-Startups
Imperagen, a Manchester-based BioTech company using AI and quantum physics to engineer better enzymes faster, has closed €5.7 million (£5 million) in Seed funding to accelerate R&D, expand its wet lab capabilities, and build out its go-to-market function over the next 18 months. The round was led by PXN Ventures with participation from Imperagen’s existing […]
The post Manchester Imperagen raises €5.8 million Seed to scale AI and quantum-powered enzyme engineering appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Even Claude agrees: hole in its sandbox was real and dangerous
1d ago
Intel's CEO reveals early hiring challenges as bankruptcy concerns deterred top talent
1d ago
OpenAI floats buy-before-your-try AI availability guarantee
1d ago
Beyond a sleek interface: The new wave of European fintech
17h ago
UK Typhoon jets fitted with bargain-bin drone busters for Middle East sorties
2d ago